Allurion Technologies Inc. (ALUR)
OTCMKTS
· Delayed Price · Currency is USD
0.740
-0.060 (-7.48%)
At close: Apr 28, 2026
Allurion Technologies Company Description
Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally.
Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
The company is headquartered in Natick, Massachusetts.
Allurion Technologies Inc.
| Country | United States |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 41 |
| CEO | Shantanu Gaur |
Contact Details
Address: 11 Huron Drive Natick, Massachusetts 01760 United States | |
| Phone | 508 647 4000 |
| Website | allurion.com |
Stock Details
| Ticker Symbol | ALUR |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US02008G1022 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Shantanu K. Gaur M.D. | Co-Founder, Chief Executive Officer, President, Principal Financial and Accounting Officer and Director |
| Ojas A. Buch | Chief Operating Officer |
| Brendan Michael Gibbons J.D. | Chief Legal and People Officer and Secretary |
| Dr. Samuel G. Levy | Co-Founder |
| Dr. Ram Chuttani M.D. | MD and Founding Partner |
| Alexandra van der Stap | Vice President of Global Marketing |
| Laurent Laffineur | Vice President of International Sales and Marketing |